CSCI (Cosciens Biopharma) Other Current Receivables : $0.12 Mil (As of Sep. 2024)

View and export this data going back to 1992. Start your Free Trial

What is Cosciens Biopharma Other Current Receivables?

Cosciens Biopharma's Other Current Receivables for the quarter that ended in Sep. 2024 was $0.12 Mil.

Cosciens Biopharma's quarterly Other Current Receivables declined from Mar. 2024 ($0.15 Mil) to Jun. 2024 ($0.12 Mil) but then increased from Jun. 2024 ($0.12 Mil) to Sep. 2024 ($0.12 Mil).

Cosciens Biopharma's annual Other Current Receivables increased from Dec. 2021 ($0.04 Mil) to Dec. 2022 ($0.05 Mil) and increased from Dec. 2022 ($0.05 Mil) to Dec. 2023 ($0.16 Mil).

Cosciens Biopharma Other Current Receivables Historical Data

The historical data trend for Cosciens Biopharma's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cosciens Biopharma Other Current Receivables Chart

Cosciens Biopharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Receivables

Get a 7-Day Free Trial

0.04

0.08

0.04

0.05

0.16

Cosciens Biopharma Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Other Current Receivables	Get a 7-Day Free Trial															0.06	0.16	0.15	0.12	0.12

Cosciens Biopharma Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

Cosciens Biopharma Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Cosciens Biopharma's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Cosciens Biopharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cosciens Biopharma Inc (NAS:CSCI) » Definitions » Other Current Receivables

Comparable Companies

Traded in Other Exchanges

0UGB:UK ET8:Germany ET8:Germany CSCI:Canada

Address

c/o Norton Rose Fulbright Canada LLP, 222 Bay Street, Suite 3000, Toronto, ON, CAN, M5K 1E7

Website

https://www.zentaris.com

Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology.